Bml Capital Management, LLC Achilles Therapeutics PLC Transaction History
Bml Capital Management, LLC
- $124 Billion
- Q1 2025
A detailed history of Bml Capital Management, LLC transactions in Achilles Therapeutics PLC stock. As of the latest transaction made, Bml Capital Management, LLC holds 3,804,921 shares of ACHL stock, worth $5.63 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,804,921
Previous 4,100,002
7.2%
Holding current value
$5.63 Million
Previous $4.67 Billion
100.0%
% of portfolio
0.0%
Previous 2.9%
Shares
3 transactions
Others Institutions Holding ACHL
# of Institutions
7Shares Held
3.86MCall Options Held
0Put Options Held
0-
Xtx Topco LTD London, X038.9KShares$57,6060.0% of portfolio
-
Brave Asset Management Inc10KShares$14,8000.0% of portfolio
-
Rhumbline Advisers Boston, MA4.48KShares$6,6300.0% of portfolio
-
Endurance Wealth Management, Inc.2KShares$2,9600.0% of portfolio
-
Gamma Investing LLC Foster City, CA806Shares$1,1920.0% of portfolio
About Achilles Therapeutics plc
- Ticker ACHL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,774,000
- Market Cap $60.3M
- Description
- Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in ...